Hutchmed (China)
HCM
Ermenegildo Zegna NV
ZGN
New Fortress Energy
NFE
Enerpac Tool
EPAC
eBay
EBAY
US Stock MarketDetailed Quotes
GLUE Monte Rosa Therapeutics
- 5.655
- -0.105-1.82%
Close Jan 17 16:00 ET
- 5.655
- 0.0000.00%
Post 16:00 ET
347.42MMarket Cap-3.18P/E (TTM)
5.910High5.550Low631.11KVolume5.790Open5.760Pre Close3.59MTurnover1.71%Turnover RatioLossP/E (Static)61.44MShares12.40052wk High1.69P/B208.86MFloat Cap3.21052wk Low--Dividend TTM36.93MShs Float45.560Historical High--Div YieldTTM6.25%Amplitude2.440Historical Low5.690Avg Price1Lot Size
Monte Rosa Therapeutics News
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | DEFA14A: Others
Monte Rosa Therapeutics | DEF 14A: Definitive information statements
Monte Rosa Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | 8-K: Current report
Monte Rosa Therapeutics | DEFA14A: Others
Monte Rosa Therapeutics | DEF 14A: Definitive proxy statements
Monte Rosa Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition